M icroRNAs (miRNAs), as important regulators of gene expression, participate in many important biological processes, such as cell proliferation, differentiation, development, and apoptosis. 1 -4 Abnormal expression of miRNAs can contribute to the development of complex diseases, such as glioblastoma (GBM). 5 -7 However, the mechanisms of how dysfunctional miRNAs lead to complex diseases are still unclear.
Accumulating evidence demonstrates that the majority of miRNAs cannot lead to abnormal phenotypes individually, 8 suggesting that complex diseases may arise from cooperative effects of multiple dysfunctional miRNAs, rather than a single miRNA. For example, Mavrakis et al 9 experimentally proved that miR-9b, miR-20a, miR-26a, miR-92, and miR-223 promote the development of T cell acute lymphoblastic leukemia (T-ALL) by cooperatively regulating a group of tumor suppressor genes, such as PTEN, BIM, PHF6, NF1, and FBXW7.
With use of a bioinformatics strategy, the cooperation of miRNAs has been widely explored on the basis of many-to-many relationships between miRNAs and their target genes. 10 -13 Shalgi et al 13 constructed a miRNA coregulation network by calculating the significance of the rate of co-occurrence in the same target genes for each pair of miRNAs. In addition, recent studies reported that some miRNAs preferentially target genes with related functions 14, 15 and that clustered miRNAs can cooperatively regulate genes located closely in the protein interaction network. 16 We reasoned that the dysregulation of some important functions in a specific disease might be associated with the cooperation of multiple miRNAs. Therefore, studying the cooperative effects of multiple dysfunctional miRNAs on certain biological processes is necessary to understand the mechanisms underlying cancer development.
A number of studies have proposed different computational approaches to identify miRNA-mRNA regulatory modules, in which a group of miRNAs regulate a group of mRNAs, by integrating miRNA-mRNA target information and/or expression profiles of miRNA and mRNA. 17 -24 For example, inverse expression relationships between miRNAs and mRNAs were used to identify the active miRNA-target relationships and predict the miRNA-mRNA regulatory modules related to HCV infection. 22 Recently, Zhang et al 25 developed a non-negative matrix factorization framework to identify miRNA regulatory modules through further inclusion of gene-gene interaction network. However, it was observed that many of the identified regulatory modules were not associated with any specific functions. Thus, an approach to determine the specific functions coregulated by dysfunctional miRNAs is needed, which can lead to comprehensive interpretation of the roles of cooperating miRNAs in complex diseases.
In this study, we proposed a multistep method to identify dysfunctional miRNA-mRNA regulatory modules (dMiMRMs) under a specific condition by integrating the expression profiles of miRNA and mRNA, miRNA target information, gene ontology (GO) functional annotation, and protein interaction networks. We applied this method to identify common and specific GBM-associated dMiMRMs. The results showed that different GBM subtypes shared common cooperative mechanisms of multiple dysfunctional miRNAs, and some had subtype-specific dMiMRMs. In addition, personalized dMiMRMs were found in different patients with GBM. Our approach can be applied to other diseases and can be helpful for finding dMiMRMs.
Materials and Methods

Data
Expression Profiles of miRNA and mRNA.-The miRNA and mRNA expression profiles of GBM were collected from The Cancer Genome Atlas (TCGA) profiles. 26 The expression profiles were preprocessed by quantile normalization. We calculated the mean expression level for each gene across the replicate samples from the same individual. The miRNA and mRNA expression profiles comprised 388 common individuals, including 378 patients with GBM and 10 normal individuals. The miRNA and mRNA expression datasets consisting of 470 human miRNAs and 11273 genes, respectively, were used for subsequent analysis.
miRNA Target Relationships.-The predicted targets of miRNAs were obtained from 7 target prediction algorithms, including TargetScan, 27 miRanda, 28 PicTar, 29 miRBase Targets, 30 RNAhybrid, 30 DIANA-microT, 31 and RNA22.
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The miRNA-target relationships, which were predicted by at least 3 algorithms, were selected as the reliable miRNA-target interaction set and were used for subsequent analysis. Finally, we obtained 52 828 miRNA-target relationships between 566 miRNAs and 8085 genes.
GO Biological Processes.-GO biological processes were structured as a hierarchical directed acyclic graph. The hierarchy relationships between GO biological processes and the root term were downloaded from http://www.geneontology.org. Only the GO biological processes with hierarchical levels ≥ 4 were selected. The mapping relationships between the genes and GO biological processes were obtained from ftp://ftp. ncbi.nih.gov/gene/DATA/gene2go.gz.
Protein Interaction Network.-The protein interaction network was obtained from the Human Protein Reference Database. 33 We extracted the maximum component of the protein interaction network, which contained 9219 genes and 36 900 interactions.
Methods
A 3-step method was proposed to identify dMiMRMs under a specific condition by integrating expression profiles of miRNAs and mRNAs, miRNA target relationships, function information, and the protein interaction network (Fig. 1) .
Identification of Dysfunctional miRNAs
We defined dysfunctional miRNAs as differentially expressed miRNAs that significantly repressed the expression of most of their targets. To determine dysfunctional miRNAs for a specific disease, differentially expressed miRNAs and genes between disease and normal samples were identified using the SAM algorithm 34 at FDR ,.05 and fold change ≥1.5. We used the hypergeometric distribution test to find the differentially expressed miRNAs whose targets were significantly enriched by inversely differentially expressed genes. For a given Step 1: Identifying dysfunctional miRNAs that were differentially expressed and significantly repressed their differential target genes. In this step, we first identified the differential miRNAs and genes between disease and normal samples and then identified the differential miRNAs with most of the targets showing significantly negative correlations.
Step 2: Mining cooperative functional units in which the dysfunctional miRNA pair cooperatively regulated function-enriched and highly interconnected differential target genes. The cooperation of a pair of miRNAs was established if their common inversely expressed targets were significantly involved in any biological processes, in each of which the common inversely expressed targets showed high interconnections in the protein interaction network. Finally, the paired miRNAs and their cooperative functions consisted of a cooperative functional unit.
Step 3: Assembling cooperative functional units into dMiMRMs. Multiple cooperative functional units linking with the same function were merged to form a dMiMRM. (See Methods Section for details).
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differentially expressed miRNA, the significance level was calculated as follows:
where N is the number of genes in the mRNA expression profile, n is the number of target genes of the miRNA, M is the number of inversely differentially expressed genes, and m is the number of inversely differentially expressed genes targeted by the miRNA. If P , .05, the miRNA was identified as a dysfunctional miRNA.
Mining Cooperative Functional Units
We defined a cooperative functional unit as a pair of dysfunctional miRNAs and a function (GO biological process) cooperatively regulated by these 2 miRNAs through their common inversely differentially expressed targets, which were highly interconnected in the protein interaction network. First, for a pair of dysfunctional miRNAs with the same differential expression pattern, we identified their common inversely differentially expressed targets and performed a functional enrichment analysis to identify significantly enriched GO biological processes. For each GO biological process, we used the hypergeometric distribution test to compute a P value that represents the significance of the overlap between the coregulated inversely differentially expressed genes and genes annotated in the biological process:
where N BP is the total number of genes annotated in the GO biological process, n is the number of cotargeted inversely differentially expressed genes, M is the number of genes annotated in the biological process, and m is the number of the inversely differentially expressed genes cotargeted by the pair of miRNAs in the biological process. If P , .05, then the biological process was identified as a significantly enriched function and the cotargeted inversely differentially expressed genes in this biological process comprised a functional module.
Next, for each functional module with specific biological process, if it contained at least 3 cotargeted inversely differentially expressed genes, these genes in the functional module were mapped to the protein interaction network. We determined 2 topological features: the characteristic path length and the minimum length of the shortest paths between every inversely differentially expressed target and others in the functional module. If the minimum length of the shortest paths was ≤2 and the characteristic path length was ≤4, the function module was identified as a cooperative function regulated by the pair of dysfunctional miRNAs. The pair of dysfunctional miRNAs, together with this functional module with specific biological process, was considered as a cooperative functional unit.
Mining dMiMRMs
The identified cooperative functional units were assembled into dMiMRMs. For a given biological process, if it was linked to .1 cooperative functional unit, all of the dysfunctional miRNA pairs, together with the functional modules of this biological process in the cooperative functional units, formed a dMiMRM.
Cross-Validation
A 5-fold cross-validation was performed to validate our method. Disease samples and normal samples were randomly partitioned into 5 disease groups and 5 normal groups, respectively. The disease and normal groups were randomly combined into 5 case-control datasets. Each dataset was in turn considered as the test set, and the remaining 4 datasets were considered as the training set. On the basis of our approach, the training set was used to identify dMiMRMs. We then obtained the expression levels of miRNAs and mRNAs in the dMiMRMs from the training expression dataset. We trained an SVM classifier using the expression levels of miRNAs and mRNAs in the dMiMRMs and classified the samples in the test set. The accuracy was defined as the proportion of samples correctly classified in all the samples of the test dataset.
Results
Identification of dMiMRMs in GBM
We applied our approach to a GBM-related miRNA and mRNA expression dataset including 378 patients with GBM and 10 normal samples for mining GBM-associated dMiMRMs. Using 5-fold cross-validation, we found that the miRNAs and mRNAs in dMiMRMs could perfectly and correctly classify samples in the test data. The mean accuracy was 100%.
We identified 5 GBM-associated dMiMRMs (Fig. 2) . The epidermal growth factor receptor signaling pathway module, nerve growth factor receptor signaling pathway module, neuron differentiation module, and synaptic transmission module were cooperatively regulated by 4 up-regulated dysfunctional miRNAs (hsa-miR-15a, hsa-miR-15b, hsa-miR-16, and hsa-miR-195). The positive regulation of transcription from the RNA polymerase II promoter module was cooperatively regulated by 7 up-regulated dysfunctional miRNAs (hsa-miR-20a and hsa-miR-19b, hsa-miR-93, hsa-miR-106b, hsa-miR130b, hsa-miR-130a, and hsa-miR-148a). Many of these miRNAs and their cooperative functions in the dMiMRMs have been demonstrated to be associated with cancer. The dysfunctional miRNAs in the dMiMRMs were highly connected to each other, suggesting that these miRNAs consistently lead to the dysregulation of the associated functions in the modules. We also found that cooperative dysfunctional miRNAs can coregulate multiple functions; for example, 4 modules were found to be cotargeted by hsa-miR-15a, hsa-miR-15b, hsa-miR-16, and hsa-miR-195, suggesting the complex regulatory mechanism of miRNAs involved in the development of cancers.
To test whether the identified dMiMRMs were associated with prognosis, we selected 356 patients with GBM who had survival data and expression profiles of miRNAs and mRNAs. For each dMiMRM, we clustered 356 patients with GBM into 2 subgroups with use of hierarchical clustering, according to the expression levels of miRNAs and mRNAs in the dMiMRM. We used the Kaplan-Meier method and log-rank test to compare the survival times of the 2 subgroups. Three of the 5 dMiMRMs could distinguish patients with GBM with good prognosis from those with poor prognosis. For the positive regulation of transcription from RNA polymerase II promoter module, the significance of difference in the survival times of the 2 subgroups was .004. The P values were .008 and .015 for the epidermal growth factor receptor signaling pathway module and nerve growth factor receptor signaling pathway module, respectively (Fig. 3A, D, and G) . To test whether miRNAs or mRNAs alone in the dMiMRMs could provide useful prognostic information, we further analyzed the prognostic values of miRNAs and mRNAs in the modules. We found that only miRNAs or mRNAs could not help in differentiating patients with good prognosis from those with poor prognosis (Fig. 3B, E , and H Fig. 2 . The 5 GBM-associated dMiMRMs identified by applying our method to 378 GBM samples and 10 normal samples. In 1 of the 5 dMIMRMs, 7 dysfunctional miRNAs, including hsa-miR-93, hsa-miR-20a, hsa-miR-19b, hsa-miR106b, hsa-miR-130a, hsa-miR-130b, and hsa-miR-148a, cooperatively regulate the function of positive regulation of transcription from RNA polymerase II promoter by targeting inversely expressed genes, including ATXN1, BCL11B, RPS6KA5, and ZPFPM2. Four miRNAs, including hsa-miR-15a, hsa-miR-15b, hsa-miR-16, and hsa-miR-195, cooperatively regulate 4 functions, including the epidermal growth factor receptor signaling pathway, neuron differentiation, the nerve growth factor receptor signaling pathway, and synaptic transmission, which form the other 4 dMiMRMs. The small dark grey circles represent dysfunctional miRNAs, the grey squares represent the common inversely expressed target genes, and the large grey circles represent the functions of the common inversely expressed target genes. The solid lines between the small dark grey circles represent the cooperation of dysfunctional miRNAs, and the dash lines between the small dark grey and large grey circles indicate that dysfunctional miRNAs cooperatively regulate the function. NEURO-ONCOLOGY † J U L Y 2 0 1 3 Fig. 3 . Survival analysis of patients with GBM grouped using hierarchical clustering based on the expression levels of miRNAs and mRNA in the dMiMRMs. Hierarchical clustering of 356 patients with GBM, according to the expression levels of miRNAs and mRNAs in a specific dMiMRM, was performed (top), and a corresponding Kaplan-Meier survival plot of the 2 subgroups of patients with GBM identified by hierarchical clustering was constructed (bottom). Hierarchical clustering dendrograms and Kaplan-Meier survival plots were generated for different dMiMRMs: the positive regulation of transcription from RNA polymerase II promoter module (A-C), the epidermal growth factor receptor signaling pathway module (D-F), and the nerve growth factor receptor signaling pathway module (G-I). A, D, and G were for both miRNAs and mRNAs; B, E, and H were for miRNAs alone; and C, F, and I were for mRNAs alone.
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for miRNAs; and Fig. 3C , F, and I for mRNAs). These results demonstrate that the identification of dMiMRMs is important for the prognosis of GBM.
Identification of GBM Subtype -Associated dMiMRMs
GBM is a highly heterogeneous tumor that has been reported to comprise multiple molecular subtypes. 35 -39 Thus, it is necessary to investigate whether there are subtype-specific dMiMRMs in addition to the common dMiMRMs identified using all GBM samples. Verhaak et al 38 analyzed 200 GBM and 2 normal brain samples from TCGA and established 4 GBM subtypes, including proneural, neural, classical, and mesenchymal subtypes, through a robust gene expression -based molecular classifier and characterized them using genomic alteration patterns. Using the same methods, we identified the subtypes of the 378 GBM samples. We obtained 840 genes that were used by Verhaak et al 38 for the classification of the subtypes of GBM. We classified the 378 GBM samples into 4 groups with use of consensus mean linkage hierarchical clustering, according to clustering stability (Supplementary Figure S1A) , which is consistent with the result presented in an earlier study. 38 Finally, these 378 GBM samples were classified into 4 subtypes, including 84 classical, 39 neural, 118 proneural, and 137 mesenchymal GBM samples (Supplementary Figure S1B) .
For each GBM subtype, we compared its miRNA and mRNA expression profiles with those in the normal samples and then identified the GBM subtype-associated dMiMRMs with use of our approach. After comparison with normal samples, we found that all of the 5 dMiMRMs identified using all the GBM samples were also observed in the classical, neural, and mesenchymal subtypes, and 2 of these 5 dMiMRMs with functions of neuron differentiation and synaptic transmission were identified in the proneural subtype (Fig. 4) . These results show the common dysfunctional mechanisms across these 4 GBM subtypes. Meanwhile, we also found 3 additional dMiMRMs in the classical and proneural subtypes, respectively ( Fig. 4B and D) . Obviously, 2 common modules occurred in both the classical and proneural subtypes, namely, a platelet activation functional module coregulated by 2 up-regulated miRNAs (hsa-miR-25 and hsa-miR-32), 2 down-regulated miRNAs (hsa-miR-29a and hsa-miR-29b), and a collagen fibril organization functional module cotargeted by hsa-miR-29a, hsa-miR-29b, and hsa-miR-29c. Of interest, a classical subtype-specific dMiMRM was observed, namely skeletal system development, which was noted to be cotargeted by hsa-miR-29a, hsa-miR-29b, and hsa-miR-29c. For the proneural subtype, a module of positive regulation of transcription from the RNA polymerase II promoter cotargeted by 2 up-regulated miRNAs (hsa-miR-106b and hsa-miR-19b) and 3 down-regulated miRNAs (hsa-miR29c, hsa-miR-29a, and hsa-miR-29b) was identified. Although the function of positive regulation of transcription from the RNA polymerase II promoter was also included in 1 of the 5 common dMiMRMs identified using all GBM samples, different compositions of miRNAs were found to influence this function in the proneural subtype (Fig. 4D) . These results suggest that some GBM subtypes have intrinsically different molecular mechanisms.
To test whether there are distinguishing dMiMRMs that could identify these 4 GBM subtypes, we compared the 4 different GBM subtypes by applying our method. Each subtype was compared with the other 3 subtypes in a pairwise manner and in a combined way. We found that there were no dMiMRMs between any pairs of subtypes when the fold change was ≥1.5. When we set the threshold of fold change at 1.2, only the comparison between the neural and mesenchymal GBM subtypes showed 5 dMiMRMs, in which the members of let-7 cooperatively regulated 5 functions, including axon guidance, platelet activation, blood coagulation, collagen fibril organization, and skeletal system development, suggesting modest differences among these 4 GBM subtypes.
Identification of Personalized dMiMRMs in GBM
In addition to identification of common modules by the application of our method to a mass of samples, we can identify personalized modules and analyze specific and common modules of patients with GBM by applying our method to individual samples.
For each patient with GBM, we compared the expression levels of miRNAs and mRNAs in that GBM sample with the respective mean expression levels of miRNAs and mRNAs across the 10 normal samples. We identified differentially expressed miRNAs and genes by fold change of ≥1.5 and then determined the dMiMRMs associated with that GBM sample using our method. We identified a total of 463 dMiMRMs for 378 GBM samples and calculated the frequencies of the dMiMRMs across the 378 GBM samples (Supplementary Table  S1 ). Only a few diMiMRMs were identified in most of the GBM samples, and the majority of dMiMRMs were only observed in a few samples (Supplementary Figure S1 ). As expected, we found that all 5 common dMiMRMs identified using all the GBM samples were included in the top 10 dMiMRMs with the highest frequencies (Supplementary Table S1 and Figure S2 ). For example, 274 and 233 GBM samples were associated with the neuron differentiation module and epidermal growth factor receptor signaling pathway module, respectively, both of which were coregulated by hsamiR-15a, hsa-miR-15b, hsa-miR-16, and hsa-miR-195. These results further support that these common dMiMRMs are indispensable for the development of GBM. Remarkably, many dMiMRMs were only identified in a few GBM samples, and patients with GBM of same subtypes also showed significantly different dMiMRMs. For example, 10 and 11 dMiMRMs were identified in 2 patients with proneural GBM (Supplementary Figure  S4A and B) . These 2 patients shared only 5 dMiMRMs with high frequencies in the GBM population, and they had their own personalized dMiMRMs. The notch signaling pathway and DNA repair modules cotargeted by hsa-miR-30b, hsa-miR-30c, and hsa-miR-30d were only observed in one patient, whereas the DNA fragmentation involved in apoptotic nuclear change and cellular component disassembly involved in apoptosis modules cotargeted by the mir-181 family were only observed in the other patient. We also compared the miRNA and mRNA expression profiles of each pair of individuals from 2 different GBM subtypes and calculated the frequencies of dMiMRMs for different comparisons of subtypes (Supplementary Table S2 ). These results are consistent with those obtained from subtype comparisons using all subtype samples (Supplementary Figure S5) . Taken together, these dMiMRMs, only observed in one or a few GBM samples, may represent personalized driver modules, which will be helpful for developing personalized treatments.
Discussion
The miRNAs play important roles in the pathogenesis of cancer by regulating important biological processes. The multiplicity of targets and cooperativity of miRNAs suggest that multiple miRNAs may cooperatively control these biological processes in complex diseases. In this study, we integrated miRNA and mRNA expression profiles, miRNA target information, and gene functional annotation information and protein interaction networks to identify dMiMRMs underlying a specific disease.
GBM is the most common and most aggressive primary brain tumor that has been reported to exhibit a mix of molecular genetic subtypes. We applied our method to GBM and identified GBM-associated common and specific dMiMRMs among the GBM samples. Using all GBM samples, we identified 5 common dMiMRMs associated with GBM. All 5 common dMiMRMs recurred in 3 subtypes, and 2 dMiMRMs were observed in the other subtype. Meanwhile, the 5 common modules showed the highest frequencies across the 378 GBM samples. These results suggest common molecular mechanisms underlying different GBM subtypes and different GBM individuals. Among these 5 common modules, the epidermal growth factor receptor signaling pathway has been reported to contribute to the pathogenesis of GBM by regulating cell growth, survival, proliferation, and differentiation. 40, 41 In addition, the importance of this pathway in GBM has been supported by the fact that the oncogenic epidermal growth factor receptor is frequently mutated and abnormally expressed in GBM. Four miRNAs, including hsa-miR-15a, hsa-miR-15b, hsa-miR-16, and hsa-miR-195, were noted to be in the epidermal growth factor receptor signaling pathway module. These 4 miRNAs have been reported to be associated with multiple cancers: 42 -46 hsa-miR-15a and hsa-miR-16 were found to be dysregulated in the progression of gliomas, 47 both of which can cooperatively work to promote tumor expansion. 48 In addition to common molecular mechanisms underlying the different GBM subtypes and individual patients, we also found that individual patients had their own personalized dysfunctional modules. The notch signaling pathway module coregulated by 3 down-regulated miRNAs, including hsa-miR-30b, hsa-miR-30c, and hsa-miR-30d, was only observed in one patient with proneural GBM. The notch signaling pathway has been found to play important roles in epithelial-mesenchymal transition (EMT) in development and tumor aggressiveness, 49 and the activation of notch signaling has been noted to promote Ras-induced transformation of glial cells, glioma growth, and survival. 50 Furthermore, the mir-30 family participated in EMT, 51 and blocking the expression of the members of mir-30 family was observed to promote tumorogenesis and metastasis. 52 Although the cooperation of the mir-181 family was observed in another proneural GBM sample, its dysfunctions were found to be associated with cell apoptosis. The mir-181 family was found to be involved in multiple cancers. 53 -55 In particular, hsa-miR-181a and hsamiR-181b have been reported to participate in the development of GBM 56 and glioma 57 as tumor suppressors. Therefore, identification of dysfunctional molecular modules at the subtype level, even at the individual level, can be helpful to explain the different clinical responses of patients with GBM to the same treatment strategy and to develop more effective therapies for personalized treatment.
However, multiple subpopulations in a single tumor have been recognized, suggesting extensive intratumor heterogeneity. 58 Expression measurements of miRNAs and mRNAs in mixed subpopulations may not exactly reflect the expression levels in a single subpopulation, which can influence identification of dMiMRMs inferred from the whole tumor. Therefore, miRNA and mRNA expression profiles from subpopulations will be required to further depict the relationships of miRNAs and mRNAs. A recent study based on single-cell sequencing further supports the intratumor heterogeneity. 59 The application of single-cell sequencing will provide an opportunity to decipher the transcriptome in single cells, which can help to identify dMiMRMs that drive the tumor progression.
When compared with the previously proposed computational approaches, our method has several advantages. First, differential expression of miRNAs has been reported in diverse human diseases, but the causal miRNAs are yet to be identified because many differentially expressed miRNAs may act as passenger miRNAs. The causal miRNAs may contribute to most of the abnormal information leading to disease by dysregulating the expression of most of their target genes. 60, 61 Distinguishing causal miRNAs from passenger miRNAs is necessary for understanding the miRNA-mediated development of a specific cancer. A recent study experimentally demonstrated that the majority of mammalian miRNAs perform their functions by decaying the mRNA levels of the target genes. 62 Active miRNA-target relationships are required to characterize the functions of miRNAs in a specific condition. Considering the differential expression of miRNAs and genes and active miRNA-target relationships can help in identifying dysfunctional miRNAs, which are more likely to be causal miRNAs.
Second, we considered gene functional annotation information from GO biological processes and topological features of genes in the protein interaction network during the mining of dMiMRMs. Although many modules identified by previously proposed computation approaches were not found to be involved in any biological processes by enrichment analysis, our approach could provide the details regarding abnormal functions cooperatively controlled by multiple dysregulated miRNAs.
Third, extensive pathogenetic heterogeneity has been reported in many human complex diseases. The diseased individuals may exhibit different patterns and compositions in the cooperation of multiple miRNAs. By applying our method to individuals with GBM, significant individual differences were observed among patients with GBM. However, the previous approaches are dependent on expression correlations between miRNAs and/or genes, which cannot identify personalized miRNA regulatory modules.
Furthermore, we compared our method with 2 previous methods. Peng et al considered differentially expressed miRNAs, without taking into account the differential expression of their targets. We applied this method to the GBM datasets and identified miRNA regulatory modules by searching the maximal bicliques (Supplementary Table S3 ) and found that most of the identified modules contained only one miRNA, which could not reflect the cooperation of multiple miRNAs. We performed functional enrichment analyses for those modules with ≥3 miRNAs and 10 targets. The results showed that most of the targets were not differentially expressed, and some of the modules were not significantly involved in any functions. A recent method proposed by Zhang et al integrated gene-gene interactions to identify miRNA-mRNA regulatory modules in a disease condition. We used that method to identify regulatory modules in GBM. The results showed that many modules were not significantly involved in any functions, which was observed using function enrichment analysis (Supplementary Table S4 ). Moreover, both these methods were found to be dependent on miRNA and mRNA expression profiles from large size disease samples, which thus, could not be used to identify personalized modules.
In conclusion, in this study, we proposed a systematic method to infer dMiMRMs under a specific disease condition by integrating multiple biological sources. We identified GBM-associated common and specific dMiMRMs among the GBM samples. Our approach can be applied to other complex diseases and can provide novel insights into how dysfunction of miRNAs contributes to the development of complex diseases.
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